Does tDCS is Effective in the Prophylactic Treatment of Migraine
Transcranial Direct Current Stimulation in the Visual Cortex of Migraine Patients: Neurophysiological and Clinical Implications
1 other identifier
interventional
36
1 country
1
Brief Summary
Migraine has been described as one of the most common neurological diseases, with high social and economic impact. Despite the high prevalence, the pathophysiology of migraine is still unknown, several studies have been developed in order to advance the understanding of the pathophysiological mechanisms of the disease which are not yet entirely elucidated. The aim of this study is to observe the effects of transcranial direct current stimulation (tDCS), applied in the visual cortex, on neurophysiological and clinical measures (frequency, intensity, duration of attacks and severity of pain) in migraine patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Oct 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 18, 2013
CompletedFirst Posted
Study publicly available on registry
June 25, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedMay 20, 2014
May 1, 2014
8 months
June 18, 2013
May 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from phosphene threshold
A 10-cm circular coil was used that has giving a peak magnetic field strength of 2 tesla. Subjects were asked to wear a blindfold, sit comfortably in a chair and to close their eyes to diminish ambient light.In sagittal line, three points were scored: 2, 3 and 4 cm above the inion. The single pulse transcranial magnetic stimulation was applied to one of the points scored and the subject was asked to report the presence or absence of a phosphene immediately after stimulation. The stimulation was repeated ten times at each intensity with a maximum frequency of 0.2 Hz, stimulation was initially applied to 60% of the maximum intensity of the stimulator. The intensity of stimulation was changed into blocks of 5% to minimum intensity that the subject can perceive the phosphene certainly, five times ten, then this value was set as the PT for migraineurs and controls.
At baseline,1 month, 2 months, 3 months/ per session - at baseline and 30 minutes (after tDCS)
Secondary Outcomes (2)
Change from eletroencephalography
At baseline, 1 month and 2 months, 3 months
Change from pain diary
3 followed months
Study Arms (3)
tDCS
EXPERIMENTALThe experimental group received tDCS to the occipital cortex in 12 sessions, 3 days per week.
control
SHAM COMPARATORThe control group received sham stimulation to the occipital cortex in 12 sessions, 3 days per week.
healthy subjects
NO INTERVENTIONThis group was submitted to one evaluation session of cortical excitability.
Interventions
tDCS involves application of very low amplitude direct current via surface scalp electrodes. The applied current modifies the transmembrane neuronal potential and thus influences the level of excitability. Depending on the polarity of active electrodes tDCS can increase or decrease the cortical excitability. The cathodal tDCS decrease the excitability, in this study a constant current of 2 mA intensity was applied for 20 min.
Eligibility Criteria
You may qualify if:
- Age must be between 18 to 40 years
- Gender: male and female
- Diagnosis must meet the 2004 IHS criteria for migraine without aura and migraine with aura
- Duration of the disease must be at least 12 months
- Patients had no preventative medication consistently for at least six months prior to study initiation.
- Age must be between 18 to 40 years
- Gender: male and female
- Individuals who have not filed headache crisis in the last year assessed according to the 2004 IHS criteria
You may not qualify if:
- Pregnant woman
- Individuals with clinical evidence of brain injury
- Metallic implant head
- Pacemaker
- History of seizure and chronic pain associated with other pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Applied Neuroscience Laboratory-LANA
Recife, Pernambuco, 50740-560, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 18, 2013
First Posted
June 25, 2013
Study Start
October 1, 2012
Primary Completion
June 1, 2013
Study Completion
October 1, 2014
Last Updated
May 20, 2014
Record last verified: 2014-05